Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/REG stock hub

FRA/REG has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/REGis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.7B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/REG

In the news

Latest news · FRA/REG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.4

P25 n/aP50 n/aP75 n/a

Trailing P/E47.2

P25 n/aP50 n/aP75 n/a

ROE45.3

P25 n/aP50 n/aP75 n/a

ROIC10.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/REG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

161

Groups with data

Currency

CNY

Showing 161 of 161 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	DE
Employees	3,048
Enterprise value	EUR 7.6B
Exchange	Frankfurt Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 7.7B
Price	EUR 10.42
Price currency	EUR
Rev Per Employee	139,492.96x
Sic	2836
Symbol	fra/REG
Website	https://www.remegen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.12%
EV Earnings	46.74x
EV/EBIT	179.61x
EV/EBITDA	93.79x
EV/FCF	1,399.03x
EV/Sales	18.2x
FCF yield	0.07%
Forward P/E	16.44x
P/B ratio	15.53x
P/E ratio	47.23x
P/S ratio	18.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.13%
EBITDA Margin	17.71%
FCF margin	1.28%
Gross margin	86.86%
Gross Profit	EUR 369.3M
Gross Profit Growth	89.23%
Gross Profit Growth Q	23.14%
Gross Profit Growth3 Y	70.69%
Gross Profit Growth5 Y	296.08%
Net Income	EUR 162.4M
Pretax Margin	38.24%
Profit Margin	38.2%
Profit Per Employee	EUR 53,292
ROA	3.38
Roa5y	-8.85
ROCE	7.19
ROE	45.33
Roe5y	-16.11
ROIC	10.27
Roic5y	-23.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	76.81x
Revenue Growth Q	24.76x
Revenue Growth3 Y	62.35x
Revenue Growth5 Y	279.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.53
Assets	EUR 926.1M
Cash	EUR 345.2M
Current Assets	EUR 512.7M
Current Liabilities	EUR 324.2M
Debt	EUR 263.4M
Debt EBITDA	EUR 3.19
Debt Equity	EUR 0.53
Debt FCF	EUR 48.53
Equity	EUR 494M
Interest Coverage	5.51
Liabilities	EUR 432.1M
Long Term Assets	EUR 413.4M
Long Term Liabilities	EUR 107.9M
Net Cash	EUR 81.9M
Net Cash By Market Cap	EUR 1.07
Net Debt EBITDA	EUR -1.09
Net Debt Equity	EUR -0.17
Net Debt FCF	EUR -15.08
Tangible Book Value	EUR 475.1M
Tangible Book Value Per Share	EUR 0.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.58
Inventory Turnover	0.66
Net Working Capital	EUR 14.2M
Quick ratio	1.26
Working Capital	EUR 190.1M
Working Capital Turnover	EUR 0.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.14%
Payout Ratio	4.72%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	10.45
All Time High	12.79
All Time High Change	-18.53%
All Time High Date	2026-04-17
All Time Low	7.7
All Time Low Change	35.32%
All Time Low Date	2026-03-04
ATR	0.36
High	10.42
High52	12.79
High52 Date	2026-04-17
High52ch	-18.53%
Low	10.42
Low52	7.7
Low52 Date	2026-03-04
Low52ch	35.33%
Ma50ch	-0.27%
RSI	44.68
RSI Monthly	0
RSI Weekly	51.4
Sharpe ratio	1.32x
Sortino ratio	2.55
Total Return	-2.14%
Tr1m	-17.33%
Tr1w	-1.37%
Tr3m	22.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 43.1M
Operating margin	10.13

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	345,189,117%
Net Borrowing	-50,983,622.4
Shares Insiders	11.77%
Shares Institutions	30.06%
Shares Qo Q	0.14%
Shares Yo Y	2.14%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 1.2M
Average Volume	33.5x
Bv Per Share	0.87
CAPEX	EUR -26.3M
Ch1m	-17.33
Ch1w	-1.37
Ch3m	22.59
Change	-2.98%
Change From Open	0
Close	10.74
Days Gap	-2.98
Depreciation Amortization	31,930,392.6
Earnings Date	2026-04-28
EBIT	EUR 43.1M
EBITDA	EUR 75.3M
EPS	EUR 0.29
F Score	7
FCF	EUR 5.4M
FCF EV Yield	0.07x
Financing CF	36,805,204
Fiscal Year End	December
Founded	2,008
Graham Number	1.82497
Graham Upside	-82.49
Income Tax	EUR 155,321
Investing CF	-19,902,629
Is Primary Listing	0
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Ma20	11.33
Ma20ch	-8.03%
Net CF	47,763,221
Next Earnings Date	2026-08-17
Open	10.42
P FCF Ratio	1,413.8
P OCF Ratio	241.5
Ppne	380,377,964.4
Price Date	2026-05-08
Price EBITDA	EUR 102
Ptbv Ratio	16.15
Relative Volume	0.93x
Revenue	425,174,529x
SBC By Revenue	1x
Share Based Comp	4,262,400
Tax By Revenue	0.04x
Tax Rate	0.1%
Z Score	7.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/REG pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns FRA/REG?

Insider, institutional, and short-interest positioning.

Institutional ownership

+30.1%

Share of float held by funds and institutions

Insider ownership

+11.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.1%

Negative means the company is buying back shares.

Technical

FRA/REG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.7

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.31

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/REG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/REG stock rating?

fra/REG is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/REG analysis?

The full report lives at /stocks/fra/REG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/REG?

The latest report frames fra/REG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/REG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.